EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSTNIG00000017623
Gene Symbol: DHCR24
2 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSTNIG00000004289
Gene Symbol: HMGCR
2 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSTNIG00000013487
Gene Symbol: HMGCRB
2 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSTNIG00000012830
Gene Symbol: PDPK1B
2 Cross references
221 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSTNIG00000002819
Gene Symbol: NT5E
3 Cross references
215 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSTNIG00000004036
Gene Symbol: HTR1AB
2 Cross references
132 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSTNIG00000018621
Gene Symbol: HTR2CL1
2 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate B

Ensembl ID : ENSTNIG00000012775
Gene Symbol: HTR5AB
2 Cross references
209 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSTNIG00000005134
Gene Symbol: HTR1A
3 Cross references
104 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSTNIG00000002818
Gene Symbol: HTR1B
3 Cross references
184 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSTNIG00000016421
Gene Symbol: HTR1F
3 Cross references
142 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSTNIG00000007161
Gene Symbol: HTR3A
2 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).